LIPO — Lipella Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$1.85m
- $0.54m
Brief: Lipella Pharmaceuticals Inc Files For Mixed Shelf Of Up To $50 Million - SEC Filing
Brief: Lipella Pharmaceuticals Marks Successful First Year With Strategic Progress And Key Milestones Accomplished
U.S. STOCKS ON THE MOVE-Paypal, Bowlero, Dycom
Brief: Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus
Brief: Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results And Corporate Update
Brief: Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement With Cook Myosite
Brief: Lipella Pharmaceuticals Doses First Patient In Human Study Of Innovative Contrast Agent
Brief: Lipella Reports 2022 Loss Per Share Of $0.64
Brief: Lipella Pharmaceuticals Appoints Daniel Cohen As A Member Of Board
Lipella Pharma up on completion of mid-stage bladder disease drug trial
Brief: Lipella Pharmaceuticals Successfully Completes Phase 2A Clinical Trial Announces Late-Breaking Presentation At The Annual Meeting Of The American Urological Association
Brief: Lipella Pharmaceuticals Announces Creation Of Oral Health Scientific Advisory Board
U.S. STOCKS ON THE MOVE-Tesla, Eton Pharma, Jack Henry & Associates
U.S. STOCKS ON THE MOVE-Levi Strauss, Salesforce, Eli Lilly
U.S. STOCKS ON THE MOVE-ProKidney Corp, Dentsply Sirona, Lipella Pharmaceuticals Inc
Lipella Pharmaceuticals surges on promising drug data in bladder disease trial
Brief: Lipella Pharmaceuticals Announces Successful Top Line Results Of Phase 2A Clinical Trial Of Lp-10
U.S. STOCKS ON THE MOVE-Nike, Venus Concept, Zymeworks
U.S. STOCKS ON THE MOVE-Nike, Venus Concept, Core Scientific, Zymeworks